ACT-051

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameACT-051
Drug Alias Namebacterial topoisomerase inhibitor (Actelion Pharmaceuticals)bacterial topoisomerase inhibitors (Idorsia)ACT-051
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActelion Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIdorsia LtdActelion Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A